Novartis Ag (NVSEF) Goodwill (2016 - 2025)
Historic Goodwill for Novartis Ag (NVSEF) over the last 17 years, with Q4 2025 value amounting to $25.6 billion.
- Novartis Ag's Goodwill rose 327.6% to $25.6 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $25.6 billion, marking a year-over-year increase of 327.6%. This contributed to the annual value of $25.6 billion for FY2025, which is 327.6% up from last year.
- Latest data reveals that Novartis Ag reported Goodwill of $25.6 billion as of Q4 2025, which was up 327.6% from $25.6 billion recorded in Q3 2025.
- In the past 5 years, Novartis Ag's Goodwill registered a high of $29.8 billion during Q2 2021, and its lowest value of $112.0 million during Q1 2021.
- For the 5-year period, Novartis Ag's Goodwill averaged around $24.1 billion, with its median value being $25.6 billion (2025).
- As far as peak fluctuations go, Novartis Ag's Goodwill crashed by 9558.01% in 2021, and later skyrocketed by 1981959.46% in 2023.
- Novartis Ag's Goodwill (Quarter) stood at $29.6 billion in 2021, then fell by 0.99% to $29.3 billion in 2022, then fell by 20.34% to $23.3 billion in 2023, then increased by 6.06% to $24.8 billion in 2024, then rose by 3.28% to $25.6 billion in 2025.
- Its Goodwill stands at $25.6 billion for Q4 2025, versus $25.6 billion for Q3 2025 and $25.6 billion for Q2 2025.